[一个儿科有毒外皮缩病例由非处方药眼滴引发]
Rena Hashimoto1, Ryo Tanaka1, Risa Fukuda1
1Dermatology, Department of Pediatric Surgery, National Center for Child Health and Development.
Arerugi = [Allergy]
|October 13, 2025
概括
一个罕见的儿童有毒表皮解 (TEN) 病例是由非处方药抗菌眼滴引发的. 用类固醇和免疫球蛋白疗法迅速治疗导致皮肤完全愈合.
科学领域:
- 皮肤病学 皮肤病学
- 眼科医生 眼科 眼科
- 儿科 儿科 儿科
背景情况:
- 毒性表皮解 (TEN) 是一种罕见的,严重的粘膜皮肤反应.
- 非处方药 (OTC) 抗菌眼滴通常用于眼部感染.
- 药物诱导的TEN在儿童中并不常见,特别是在OTC眼科制剂中.
研究的目的:
- 报告一个儿科患者罕见的TEN病例.
- 要突出OTC抗菌眼滴与严重的皮肤不良反应之间的潜在关联.
- 强调及时诊断和儿童TEN治疗的重要性.
主要方法:
- 一个10岁男孩的病例报告呈现出与史蒂文斯-约翰逊综合征 (SJS) 一致的症状.
- 临床检查显示了特征性的皮肤病变,粘膜干扰和眼部症状.
- TEN的诊断得到了通过全厚表皮亡的组织病理学发现的证实.
- 治疗包括高剂量的静脉注射免疫球蛋白和类固醇脉冲疗法.
主要成果:
- 患者在使用OTC抗菌眼滴和阿莫西西林后发展了TEN.
- 表皮脱落超过了身体表面积的30%.
- 通过实施的治疗方案,成功地实现了重新上皮质化.
- 疾病严重性得分从26提高到0.
结论:
- 在儿童中,OTC抗菌眼滴可以引发严重的皮肤反应,如TEN.
- 这是日本首次报告与OTC抗菌眼滴相关的TEN病例.
- 早期识别和积极治疗对于儿科TEN的良好结果至关重要.
更多相关视频
相关概念视频
Pharmacokinetics in Pediatric Patients: Drug Excretion
212
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
212
Pharmacokinetics in Pediatric Patients: Drug Metabolism
192
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
192
Pharmacokinetics in Pediatric Patients: Drug Distribution
252
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
252
Allergic Reactions
32.0K
Overview
32.0K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
242
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
242
Toxic Reactions: Overview
1.8K
When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
1.8K


